Zhejiang Jingxin Pharmaceutical (002020.SZ) is planning to go public in Hong Kong.

06:31 13/01/2026

Jingxin Pharmaceutical (002020.SZ) announced that the company plans to issue overseas listed shares (H shares) and apply for listing on the main board of the Stock Exchange of Hong Kong in China.

Zhejiang Jingxin Pharmaceutical (002020.SZ) announced that the company plans to issue overseas listed shares (H shares) and apply for listing on the main board of the Hong Kong Stock Exchange.

FDB Holdings (01826) will be temporarily suspended from trading starting from January 13th.

DALIPAL Holdings (01921) will resume trading on January 13th.

Pre-market update on A-shares: Chinese assets surge in the late night, with the Chinese concept stock index rising more than 4%. Gold and silver both skyrocket to refresh highs.

FDB Holdings (01826) will be temporarily suspended from trading starting from January 13th.

DALIPAL Holdings (01921) will resume trading on January 13th.

Pre-market update on A-shares: Chinese assets surge in the late night, with the Chinese concept stock index rising more than 4%. Gold and silver both skyrocket to refresh highs.